<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; NLEM2011</title>
	<atom:link href="http://www.tapanray.in/tag/nlem2011/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>The Game Changers in 2012 and A Crystal Gazing into 2013</title>
		<link>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-game-changers-in-2012-and-a-crystal-gazing-into-2013</link>
		<comments>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/#comments</comments>
		<pubDate>Mon, 31 Dec 2012 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2012]]></category>
		<category><![CDATA[2013]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Changers]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[Crystal]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Essential]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Gazing]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Natco]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[NLEM2011]]></category>
		<category><![CDATA[NPPP 2012]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1374</guid>
		<description><![CDATA[Wish You and Your Dear Ones Best of Health, Happiness, Success and Prosperity in The Brand New Year. Welcome 2013  The Global Pharmaceutical Industry (GPI), by and large, used to be considered as ‘recession-proof’ for various valid reasons. However, the &#8230; <a href="http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The New Drug Policy of India enters into the final lap of a Marathon Run</title>
		<link>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run</link>
		<comments>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/#comments</comments>
		<pubDate>Mon, 21 May 2012 00:00:54 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[DPCO]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[enters]]></category>
		<category><![CDATA[final]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[into]]></category>
		<category><![CDATA[lap]]></category>
		<category><![CDATA[Marathon]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NLEM2011]]></category>
		<category><![CDATA[NPPP2011]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Run]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=91</guid>
		<description><![CDATA[Final working out and thereafter announcement of much awaited and long overdue the new ‘Drug Policy’ of India has now entered into a very interesting stage. This is mainly because of the unique combination of the following three key reasons: &#8230; <a href="http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-new-drug-policy-of-india-enters-into-the-final-lap-of-a-marathon-run/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The New Drug Policy is languishing in a labyrinth</title>
		<link>http://www.tapanray.in/the-new-drug-policy-is-languishing-in-a-labyrinth/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-new-drug-policy-is-languishing-in-a-labyrinth</link>
		<comments>http://www.tapanray.in/the-new-drug-policy-is-languishing-in-a-labyrinth/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[control]]></category>
		<category><![CDATA[DPCO95]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[labyrinth]]></category>
		<category><![CDATA[languishing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NLEM2011]]></category>
		<category><![CDATA[NPPP 2011]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=113</guid>
		<description><![CDATA[Drug Price Control has remained the key feature of all Drug Policies of India, since their inception in early 70’s. Most of these policies continued to remain behind their times consistently, without any exception. That said, the Drug Policy 1994 &#8230; <a href="http://www.tapanray.in/the-new-drug-policy-is-languishing-in-a-labyrinth/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-new-drug-policy-is-languishing-in-a-labyrinth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
